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Cellular/Molecular

A Role for the Ubiquitin–Proteasome System in Activity-Dependent
Presynaptic Silencing
Xiaoping Jiang,1 Patricia E. Litkowski,1 Amanda A. Taylor,1 Ying Lin,2 B. Joy Snider,2 and Krista L. Moulder1
Departments of 1Psychiatry and 2Neurology, Washington University School of Medicine, St. Louis, Missouri 63110

Chronic changes in electrical excitability profoundly affect synaptic transmission throughout the lifetime of a neuron. We have previously
explored persistent presynaptic silencing, a form of synaptic depression at glutamate synapses produced by ongoing neuronal activity
and by strong depolarization. Here we investigate the involvement of the ubiquitin–proteasome system (UPS) in the modulation of
presynaptic function. We found that proteasome inhibition prevented the induction of persistent presynaptic silencing. Specifically,
application of the proteasome inhibitor MG-132 (carbobenzoxy-L-leucyl-L-leucyl-L-leucinal) prevented decreases in the size of the readily
releasable pool of vesicles and in the percentage of active synapses. Presynaptic silencing was accompanied by decreases in levels of the
priming proteins Munc13-1 and Rim1. Importantly, overexpression of Rim1␣ prevented the induction of persistent presynaptic silencing. Furthermore, strong depolarization itself increased proteasome enzymatic activity measured in cell lysates. These results suggest
that modulation of the UPS by electrical activity contributes to persistent presynaptic silencing by promoting the degradation of key
presynaptic proteins.

Introduction
Chronic changes in electrical excitability profoundly affect synaptic transmission during development and throughout life.
Neurons adapt to changing electrical activity patterns in a plastic
manner by upregulating or downregulating subsequent synaptic
signaling. This activity-dependent plasticity takes on many
forms, from Hebbian feedforward strengthening of synapses to
homeostatic depression of global synaptic activity. Because it is of
opposite polarity to the inducing stimulus, homeostatic plasticity
may be an important adaptive response to prevent excitotoxicity
or runaway excitation or simply to keep Hebbian mechanisms
(e.g., long-term potentiation) from saturating synaptic machinery (Turrigiano and Nelson, 2004). We have described a presynaptic form of adaptive plasticity that we refer to as persistent
presynaptic silencing, which operates over a wide range of activity
in hippocampal neurons (Moulder et al., 2004, 2006). Presynaptically silenced neurons exhibit reduced glutamate release after a
period of increased spiking or tonic depolarization. The exact
mechanism responsible for decreased glutamate signaling is unknown but appears to involve compromised synaptic vesicle
priming (Moulder et al., 2006).
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Recently, the synaptic vesicle priming protein Rim1␣ has been
shown to be a substrate of the ubiquitin–proteasome system
(UPS) (Yao et al., 2007). The proteasome is a proven regulator of
postsynaptic function, with targets including AMPA receptors,
PSD-95, and the spine-associated Rap GTPase activating protein
(Burbea et al., 2002; Colledge et al., 2003; Ehlers, 2003; Pak and
Sheng, 2003; Patrick et al., 2003; Bingol and Schuman, 2006). The
UPS also has a critical role in synaptogenesis and synapse elimination (for review, see Haas and Broadie, 2008), mediated in
some settings by the ability of select ubiquitin ligases to be trafficked to specific synapses (Ding et al., 2007). Last, considerable
work in invertebrate systems has demonstrated that the UPS can
affect neurotransmitter release (Aravamudan and Broadie, 2003;
Speese et al., 2003; Zhao et al., 2003; Fioravante et al., 2008).
Despite these advances, however, research into the role of the proteasome at mammalian presynaptic sites is a nascent field. Recent
work in hippocampal neurons confirms that the proteasome modulates the size of the recycling pool of synaptic vesicles in a manner
likely tied to electrical activity (Willeumier et al., 2006).
We explored the hypothesis that the UPS participates in
depolarization-induced persistent presynaptic silencing in hippocampal neurons. We found that presynaptic silencing was accompanied by decreases in the synaptic and cellular levels of
Rim1 proteins, as well as those of another priming protein,
Munc13-1. Proteasome inhibition prevented both the induction
of presynaptic silencing and the decreases in Rim1 and Munc13-1
proteins. These decreases were likely attributable to increased
proteasomal degradation as depolarization enhanced proteasome enzymatic activity. Finally, overexpression of Rim1␣ also
prevented induction of presynaptic silencing. We conclude that
modulation of the presynaptic proteasome complex by electrical
activity governs glutamate release through control of key vesicle
priming proteins.
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Materials and Methods
Cell culture. Hippocampal cultures were prepared as described previously (Mennerick et al., 1995). In brief, dissected postnatal (postnatal
days 0 –3) rat hippocampi were incubated with papain and then mechanically dissociated and plated at either ⬃650 cells/mm 2 as “mass”
cultures or 100 cells/mm 2 on microdots of collagen as “microisland”
cultures. Plating medium consisted of Eagle’s medium (Invitrogen)
supplemented with heat-inactivated horse serum (5%), fetal bovine
serum (5%), 17 mM glucose, 400 M glutamine, 50 U/ml penicillin,
and 50 g/ml streptomycin. Cultures were maintained at 37°C in a
humidified incubator with 5% CO2/95% air. Cytosine arabinoside at
6.7 M was added at 3– 4 d after plating to inhibit cell division. At 1 d
(mass cultures) or 4 –5 d (microisland cultures), a medium exchange
was performed with Neurobasal medium (Invitrogen) plus B27
supplement.
Some transfection experiments were performed on microisland
cultures prepared on microstamped coverslips. To prepare these cultures, 25 mm coverslips were shaken in 95% ethanol overnight. Coverslips were then washed with water and autoclaved, precoated with
0.15% agarose type II-A (Sigma), and allowed to dry. After drying,
collagen was applied to a polydimethylsiloxane stamp (Moulder et al.,
2007), which had been cleaned using a PDC-001 plasma cleaner (Harrick Plasma). The collagen was then stamped onto the coverslip and
exposed to ultraviolet light for 45 min. Cortical astrocytes (obtained
as in the study by Rose et al., 1992) were plated on stamped coverslips in plating medium (above). After 3– 6 d, hippocampal neurons
obtained as above were plated at 25 cells/mm 2 onto the astrocyte
microislands. Transfections were performed using either these microstamped coverslips (see Fig. 8 A–D) or mass cultures (see Fig. 8 E)
(supplemental Fig. 1, available at www.jneurosci.org as supplemental
material) at 9 –14 d after neuronal plating using Lipofectamine 2000
(Invitrogen) (Moulder et al., 2007). Green fluorescent protein (GFP)
was obtained from Genlantis, the Rim1␣ construct was a kind gift
from Dr. Thomas Südhof (Stanford University, Palo Alto, CA), and
the synaptophysin–yellow fluorescent protein (YFP) construct was a
kind gift from Dr. Ann Marie Craig (University of British Columbia,
Vancouver, British Columbia, Canada).
Experiments were conducted at 11–14 d in vitro (DIV). Presynaptic
silencing can be induced with different depolarizing stimuli, although the
degree of depolarization and the time of exposure are inversely linked.
For example, manipulations of neuronal spiking within the physiological
range of activity require several days to depress glutamate release (Moulder et al., 2006). To avoid potential confounds (of proteasome inhibitors
or other pharmacological agents) on neuronal survival (Ding and Keller,
2001; Snider et al., 2002; Reaney et al., 2006) or development, we focused
here on strong stimulation, in which manipulations can be completed
in a matter of hours (Moulder et al., 2004, 2008). [K ⫹]o was elevated
from 5 to 35 mM for 4 h as indicated, with equimolar NaCl added to
control cultures to match osmotic changes. D-2-Amino-5-phosphonovalerate (D-APV) at 25 M and 1 M 2,3-dihydroxy-6-nitro-7sulfonyl-benzo[f]quinoxyline (NBQX) were added to control and
experimental dishes during this treatment, which we refer to throughout the text as “depolarization.”
Hippocampal slice preparation. Some Western blotting experiments
shown in Figure 7 were performed using acute hippocampal slice tissue
to increase the amount of total protein available for Western blot analysis. (No other experiments used acute slices.) We have confirmed previously that persistent presynaptic silencing can be induced in acute
hippocampal slices (Moulder et al., 2004). Slices were prepared as described previously (Meeks and Mennerick, 2004). In brief, anesthetized
Sprague Dawley rats (14 –21 d postnatal) were decapitated, and 300 m
coronal slices of the hippocampus were cut with a vibratome. Slices were
then held at room temperature for 60 min with a bath solution containing the following (in mM): 125 NaCl, 2.5 KCl, 1 MgCl2, 2 CaCl2, 25
dextrose, 1.25 NaH2PO4, 0.4 ascorbic acid, 3 myo-inositol, 2 sodium
pyruvate, 25 NaHCO3, 2 mM kynurenate (pH 7.4 when bubbled with
95% O2/5% CO2). After this recovery period, slices were either maintained in bath solution for 4 h (control) or depolarized in bath solution.
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Both conditions also received 25 M D-APV and 1 M NBQX. To maintain proper osmolarity, NaCl was reduced to 95 mM when the additional
30 mM KCl was added for the depolarization.
FM1-43FX labeling and immunocytochemistry. Mass cultures plated on
coverslips were used for all imaging experiments. Neurons were exposed for 2 min to 10 M FM1-43FX [fixable version of N-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl) pyridinium dibromide]
(Invitrogen) and 45 mM K ⫹ (equimolar substitution for Na ⫹) in extracellular recording saline containing the following (in mM): 138 NaCl, 4
KCl, 2 CaCl2,1 MgCl2, 10 glucose, 10 HEPES, 0.025 D-APV, and 0.001
NBQX, pH 7.25. Cultures were washed for 5 s with extracellular recording saline containing 500 M Advasep-7 (CyDex) to remove nonspecific
dye (Kay et al., 1999) and then washed in saline alone for 10 min. Cultures were fixed in 4% paraformaldehyde/0.2% glutaraldehyde in PBS,
pH 7.4, for 10 min.
For subsequent antibody staining, cells were washed with PBS and
incubated in blocking solution (4% normal goat serum/0.04% Triton
X-100 in PBS) for 15 min, followed by vesicular glutamate transporter
vGluT-1 primary antibody (Millipore Corporation) in blocking solution
(1:2000 dilution for 3 h). Cells were washed with PBS and then incubated
with Alexa 647-conjugated anti-guinea pig antibody (1:500 in blocking
solution; Millipore Corporation) for 30 min. Coverslips were then
washed with PBS and mounted with Fluoromount-G (Southern Biotechnology Associates).
For vGluT-1/Munc13-1 costaining, cells were fixed in cold 100%
methanol for 10 min. Munc13-1 primary antibody (Synaptic Systems) was used at 1:1000. Secondary antibodies were Alexa 488conjugated anti-guinea pig and Alexa 633-conjugated anti-rabbit
(both at 1:500; Invitrogen). For vGluT-1/Rim1 costaining, cells were
fixed in 4% paraformaldehyde in PBS. Rim1 primary antibody (BD
Biosciences) was used at 1:500. Secondary antibodies were Alexa 488conjugated anti-guinea pig and Alexa 647-conjugated anti-mouse
(both at 1:500; Invitrogen). Bassoon antibody (Synaptic Systems) was
used at 1:500 with cells fixed in 4% paraformaldehyde in PBS. Rab3
antibody (Synaptic Systems) was used at 1:500 with cells fixed in 4%
paraformaldehyde in PBS. Syntaxin1A (Synaptic Systems) was used at
1:2000 with cells fixed in 4% paraformaldehyde in PBS. VAMP2 (Synaptic Systems) was used at 1:1000 with cells fixed in 4% paraformaldehyde/0.2% glutaraldehyde in PBS.
For experiments in which Munc13-1 and vGluT-1 immunocytochemistry was performed in conjunction with FM1-43 uptake, FM1-43FX
labeling was performed identically to other experiments, but cells were
fixed in 4% paraformaldehyde/0.025% glutaraldehyde. vGluT-1 antibody was used at 1:2000 and Munc13-1 antibody was used at 1:500.
Secondary antibodies were Alexa 555-conjugated anti-rabbit and Alexa
633-conjugated anti-guinea pig (both at 1:500; Invitrogen). For experiments in which Rim1 and vGluT-1 immunocytochemistry was performed in conjunction with FM1-43 uptake, FM1-43FX labeling was
performed identically to other experiments, but cells were fixed in 4%
paraformaldehyde/0.03% glutaraldehyde. Secondary antibodies were
cyanine 3 (Cy3)-conjugated anti-mouse and Alexa 647-conjugated antiguinea pig (both at 1:500; Invitrogen).
For transfection experiments in which Munc13-1 and vGluT-1 immunocytochemistry was performed in neurons expressing synaptophysin–
YFP, cells were fixed in 4% paraformaldehyde in PBS and permeabilized
in 0.1% Triton X-100. vGluT-1 was used at 1:2000, and Munc13-1 was
used at 1:500. Secondary antibodies were Cy3-conjugated anti-guinea
pig and Alexa 647-conjugated anti-rabbit.
All stains were examined by confocal microscopy performed using
a 60⫻ objective (1.4 numerical aperture), a C1 scanning confocal
laser attached to an inverted Eclipse TE2000 microscope (Nikon), and
Z-1 software (Nikon). An observer naive to experimental conditions
acquired images of representative fields in z-stack using alternating
excitation by the 488, 543, and/or 633 laser lines as appropriate. Gain
settings, dwell time, field of view size, and z-stack parameters were
kept constant for all images within an experiment. Monochrome images were converted into projected images and analyzed using MetaMorph software (Universal Imaging). Ten puncta per field and five
fields per condition were analyzed for each experiment. Staining was
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thresholded separately for images from each laser line. vGluT-1positive puncta were always defined first, without reference to images
from other laser lines. Regions identified in the vGluT-1 image were
then transferred to other images. Regions with FM1-43FX staining
exceeding a criterion of ⬎10 pixels were considered active presynaptic terminals (Moulder et al., 2006, 2008). For experiments in which
Rim1 or Munc13-1 immunoreactivity was examined in nonsynaptic
locations, intensity was measured in a 5 ⫻ 5 pixel square placed
immediately adjacent to the region of a defined synaptic punctum but
still within the clearly visible neurite.
Electrophysiology. Solitary microisland neurons were used for all electrophysiology experiments. Control and experimental conditions were
always performed on sibling cultures from the same litter and plating and
on the same day of recording.
Whole-cell recordings were performed using an Axopatch 1D amplifier (Molecular Devices) and a Digidata 1322 acquisition board (Molecular Devices). Electrodes had resistances of 3–5 M⍀, and access resistance
was compensated 80 –100%. In all instances, cells were excluded from analysis if a leak current ⬎300 pA was observed. For recording, the culture
medium was exchanged for recording solution containing the following
(in mM): 138 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 glucose, 10 HEPES, and
0.025 D-APV, pH 7.25. The whole-cell pipette solution contained the
following (in mM): 140 K-gluconate, 0.5 CaCl2, 5 EGTA, and 10 HEPES,
pH 7.25. For synaptic recordings, cells were stimulated with 1.5 ms pulses
to 0 mV from ⫺70 mV to evoke transmitter release (Mennerick et al.,
1995). For hypertonic solution (0.5 M sucrose), application time was 3 s.
Sucrose responses were integrated to include responses beneath the transient peak of the response to 10% of the steady-state response.
Immunoblotting. For cultured neurons, treated cells were washed twice
in PBS and then lysed in 1⫻ reducing Laemmli’s sample buffer plus
protease inhibitors (10 g/ml leupeptin and 20 g/ml aprotinin). One 35
mm dish was lysed per condition; four lanes of each condition (lysed
separately) were loaded per experiment to account for dish-to-dish variability in cell number. For hippocampal slices, tissue was sonicated in
radioimmunoprecipitation assay buffer (150 mM NaCl, 50 mM Tris, 0.5%
deoxycholic acid, 0.1% SDS, 1% Triton X-100, and 2.5 mM EDTA, pH
8.0) plus protease inhibitors. Three to four slices per condition were
loaded per experiment. Slices in each condition were matched for their
anteroposterior position within the hippocampus.
Individual samples were separated under reducing conditions using
4 –12% Bis-Tris or 3– 8% Tris-acetate NuPAGE gels (Invitrogen) and
transferred to nitrocellulose. Blots were incubated in 3% nonfat dried
milk (NFDM) dissolved in TTBS buffer (20 mM Tris, 0.137 M NaCl, and
0.1% Tween 20, pH 7.6). Primary and HRP-conjugated secondary antibodies were diluted in 1% NFDM in TTBS. Bands were detected with
Lumigen-TMA6 (GE Healthcare) or SuperSignal West Pico Chemiluminescent Substrate (Pierce) and captured digitally using the Kodak ImageStation 440CF. Densitometry was performed using the Kodak 1D
Image Analysis software.
Primary antibody concentrations were as follows: Munc13-1 (1:1000),
Rim1 (1:1000), Bassoon (1:500), Rab 3 (1:2000), Rabphilin (1:500; Abcam), Munc18 (1:10,000; BD Bioscience), ␣SNAP (1:500; Santa Cruz
Biotechnology), SNAP-25 (1:2000; Millipore Corporation), Syntaxin1
(1:1000; Synaptic Systems), VAMP2 (1:100,000), and vGluT-1 (1:500).
Blots were stripped with Restore Western Blot Stripping Buffer (Pierce)
and reprobed with tubulin antibody (1:4000, Sigma) as a total protein
control or SV2 antibody (1:1000; Developmental Studies Hybridoma
Bank, University of Iowa) as a presynaptic protein control.
Proteasome enzymatic assay. Proteasome enzymatic activity was measured using a microtiter plate assay as described previously (Qiu et al.,
2000; Snider et al., 2002; Lee et al., 2004). Cells were lysed in 10 mM Tris,
1 mM EDTA, 2 mM ATP, 20% glycerol, and 4 mM DTT before sonication.
Protein concentrations were measured using a Coomassie assay. Protein
(2.5 g) was assayed for the LLVY (Leu-Leu-Val-Tyr) proteasome activity in a 50 l reaction containing the following: 0.5 mM EDTA, 40 M
LLVY–7-amino-4-methylcoumarin (AMC) (Sigma), and 50 mM TrisHCl, pH 8.0. After 1 h at 37°C, the reaction was quenched with ice-cold
water, and fluorescence was measured on a CytoFluor II plate reader
(Perseptive Systems) with an excitation/emission of 360/440 nm. Back-

ground fluorescence was determined by omitting extract. A standard
curve was constructed using AMC (Sigma). Samples were assayed in
quadruplicate.
Toxicity assays. Toxicity of proteasome inhibitors was assessed after
treatment with two independent assays. First, neurons were counted
under phase-contrast optics using an inverted Nikon TE300 microscope.
Cells were counted as live if soma retained a smooth phase-bright appearance with visible, intact neuritic processes. Second, propidium iodide (PI) was added to a final concentration of 0.5 g/ml, and cultures
were returned to a 37°C incubator for 1 h. Fluorescent nuclei were then
counted on an inverted Nikon TE200S microscope. In all instances, the
rater was naive to the experimental conditions.
Reagents. All reagents were obtained from Sigma unless otherwise
indicated. MG-132 (carbobenzoxy-L-leucyl-L-leucyl-L-leucinal) and epoxomycin were obtained from Biomol. MDL 28170 (carbobenzoxyvalinyl-phenylalaninal) was obtained from EMD Biosciences.
Data acquisition and statistics. pClamp software, version 9 (Molecular
Devices), was used for electrophysiology data acquisition and analysis for
all experiments. Data plots were created with SigmaPlot software (SPSS).
Data are presented in the figures and text as mean ⫾ SEM. Paired and
unpaired t tests were used to evaluate statistical significance between
experimental conditions.

Results
Proteasome inhibition interferes with induction of persistent
presynaptic silencing
The UPS is a regulator of postsynaptic function at both glutamate
and GABA synapses (Burbea et al., 2002; Colledge et al., 2003;
Ehlers, 2003; Pak and Sheng, 2003; Patrick et al., 2003; Bingol and
Schuman, 2006; Saliba et al., 2007). Recently, increasing evidence
suggests an additional role for the UPS in modulating neurotransmitter release at mammalian synapses. The UPS directly
regulates levels of the synaptic vesicle priming protein Rim1␣
(Yao et al., 2007), and work in hippocampal neurons confirms
that the proteasome can modulate the recycling pool of synaptic
vesicles (Willeumier et al., 2006). We therefore tested whether the
UPS plays a role in the induction of persistent presynaptic silencing, which we have shown previously is likely attributable to a
defect in synaptic vesicle priming (Moulder et al., 2006). Presynaptic silencing can be induced with different degrees of depolarizing challenge; we focused here on brief depolarization to avoid
confounding effects of intervention on development and survival
(see Materials and Methods).
We depolarized hippocampal neurons in the presence or absence of 3 M MG-132, a reversible proteasome inhibitor. We
first assessed presynaptic function using FM1-43 uptake; silent
terminals are identified as glutamate synapses that immunolabel
with an antibody against vGluT-1 but do not label with FM dyes.
Similar to our previous studies, we found that depolarization
produced strong presynaptic silencing (Fig. 1 A, D). However,
addition of the proteasome inhibitor simultaneous with the depolarizing stimulus prevented the induction of presynaptic silencing (Fig. 1 A, D). MG-132 addition alone had no significant
effect on the percentage of silent synapses (Fig. 1 D), but we did
observe that proteasome inhibition increased the average
integrated intensity of individual FM1-43 puncta by 29.1%
[1.32 ⫾ 0.12 ⫻ 10 6 arbitrary units (AU) for control baseline;
1.87 ⫾ 0.23 ⫻ 10 6 AU for control plus MG-132; p ⬍ 0.05].
Because FM1-43 integrated intensity reflects the size of the recycling pool of synaptic vesicles at individual terminals, this is consistent with published evidence that proteasome inhibition
increases the size of the recycling vesicle pool (Willeumier et al.,
2006). Although our measured increase of 29.1% is smaller than
the effect of proteasome inhibition reported by Willeumier and
colleagues, our experiments were performed at 11–14 DIV. A
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Figure 1. Proteasome inhibition prevents induction of persistent presynaptic silencing. A, Merged images of FM1-43FX stain of active synapses (green) and vGluT-1 immunoreactivity (red) to
reveal all glutamatergic terminals. Images are from control (untreated) hippocampal neurons, after a 4 h exposure to 3 M MG-132, or after depolarization in the presence or absence of MG-132.
B, C, Representative traces of autaptic action potential-evoked (B) and sucrose-evoked (C) EPSCs recorded under the same conditions as in A. D–F, Summary of quantitative results from the
FM1-43/vGluT-1 correspondence assay (D), from action potential-evoked EPSCs (E), and responses to hypertonic sucrose application (F ). n ⫽ 15 each; *p ⬍ 0.001 compared with the depolarized
baseline condition.

larger effect on recycling pool size might have been detectable in
older neurons (Willeumier et al., 2006). Average FM1-43 integrated intensity of active synapses was unchanged in depolarized
neurons (with or without MG-132) compared with control.
Because the FM1-43/vGluT-1 assay measures all releasecompetent vesicles at individual synapses, we also wanted to test
whether proteasome inhibition prevented effects of depolarization on glutamate release triggered by single action potentials.
For these studies, we used autaptic hippocampal cultures. MG132 at 3 M prevented the decrease in EPSC amplitude induced
by depolarization when administered simultaneously with the
challenge (Fig. 1 B, E). We also used brief hypertonic sucrose application to measure the size of the readily releasable pool (RRP)
of vesicles (Rosenmund and Stevens, 1996; Moulder and
Mennerick, 2005) in the same neurons in which we recorded
EPSCs. As with EPSC amplitude, proteasome inhibition prevented the decrease in sucrose response charge induced by depolarization (Fig. 1C,F ). We did not, however, detect significantly
larger EPSCs or sucrose responses during proteasome inhibition
in control cultures (Fig. 1 B, C, E, F ), despite the FM1-43-defined
increase in the size of the recycling vesicle pool. This apparent
discrepancy could be attributable to the fact that EPSC and sucrose measurements rely on the combined outputs of thousands
of synapses, and the synapse number variability among neurons
obscures small differences at individual synapses. Alternatively,
because the RRP is only a subset of the recycling pool of vesicles
(Pyle et al., 2000), our result could also suggest that proteasome
inhibition increases the size of the recycling pool not by modulating RRP size but by mobilizing the reserve vesicle pool.
Effects of proteasome inhibition on persistent presynaptic
silencing are specific and unrelated to neurotoxicity
Proteasome inhibition in intact cells, particularly neurons, can be
complicated by both toxicity and a lack of specificity of the inhib-

itors. To ensure that our observed effects on glutamate release
were attributable to a specific blockade of proteasome enzymatic
activity, we performed a series of controls. Three protease enzymatic activities are associated with the core domain: a chymotrypsinlike activity, a trypsin-like activity, and a peptidylglutamyl
peptidase activity (for review, see Smalle and Vierstra, 2004). The
chymotrypsin-like activity (cleaving at LLVY) is considered to be
the main, or most active, activity of the proteasome (Orlowski
and Wilk, 2000). We therefore measured the chymotrypsin-like
activity of the proteasome in hippocampal neurons exposed to
0.3 or 3 M MG-132 for 4 h (Fig. 2 A). We found that 0.3 M
MG-132 inhibited 50.9 ⫾ 4.4% and 3 M MG-132 inhibited
83.2 ⫾ 0.4% of control levels of chymotrypsin-like activity. Acute
addition of 1 M MG-132 to control lysate inhibited 93.3 ⫾ 1.0%
of control levels of chymotrypsin-like activity. These results indicate that 4 h treatment with 3 M MG-132 inhibited a significant
amount of proteasome enzymatic activity in hippocampal neurons. To test whether this treatment was neurotoxic, neuronal
cell counts were performed on sibling cultures after 4 h exposure
to MG-132. Neither 0.3 nor 3 M MG-132 had a significant effect
on neuronal cell number (Fig. 2 B). In parallel experiments, we
also assessed PI exclusion in neurons after 4 h exposure to MG132 to assay dying neurons. The number of neurons labeled with
PI was unchanged after MG-132 treatment (Fig. 2C). These results are consistent with our previous work in cortical and striatal
neurons, which indicated that ⱖ16 h of exposure to proteasome
inhibitors is required to induce neurotoxicity (Snider et al.,
2002).
MG-132 has also been reported to inhibit calpain activity
(Meng et al., 1999). To test whether calpains could mediate persistent presynaptic silencing, we depolarized neurons in the presence or absence of 20 M MDL 28170, also known as calpain
inhibitor III (Pottorf et al., 2006). MDL 28170 did not prevent
induction of presynaptic silencing, as assessed by FM1-43 uptake
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(Fig. 2 D), whereas 3 M MG-132 did prevent silencing in sibling cultures. In addition, we also reproduced the antisilencing effects of MG-132 with a more
specific and irreversible proteasome inhibitor, epoxomycin (Meng et al., 1999),
at 30 nM (Fig. 2 E). Because 4 h epoxomycin treatment also resulted in a significant
loss of neurons (38.0 ⫾ 16.2% decrease;
p ⬍ 0.01; n ⫽ 3), we performed all subsequent experiments with MG-132. These
results confirm that the synaptic effects of
MG-132 are attributable to proteasome
blockade and not calpain inhibition, a
particularly important point because calpains could be activated by calcium influx
caused by depolarization.
Figure 2. Effects of MG-132 are specific to the proteasome and unrelated to neurotoxicity. A, Summary of the chymotrypsin-like
Depolarization, but not cAMP
(LLVY) activity of the proteasome, measured in lysates from control neurons and from neurons treated with MG-132 for 4 h. The
signaling, modulates proteasome
effect of 1 M MG-132 added acutely to control lysate was also measured. n ⫽ 4; p ⬍ 0.03. B, C, Lack of MG-132 toxicity over 4 h
enzymatic activity in hippocampal
was verified using live cell counts in sibling cultures to those examined in A (B) and using propidium iodide exclusion in separate
neurons
experiments (C). For B, n ⫽ 30; for C, n ⫽ 3. D, E, Summary of quantitative results from FM1-43/vGluT-1 correspondence assays
Because MG-132 prevented induction of performed after 4 h treatment with 3 M MG-132, 20 M MDL 28170 (D), or 30 nM epoxomycin (E) in the presence or absence of
persistent presynaptic silencing (Fig. 1), depolarization. For D and E, n ⫽ 10. *p ⬍ 0.001 compared with the depolarized baseline condition.
we next asked whether depolarization alters proteasome enzymatic activity. We
depolarized hippocampal neurons in the presence or absence of
MG-132 and then measured the chymotrypsin-like activity of the
proteasome. Four hours of strong depolarization significantly increased proteasome enzymatic activity, which was inhibited by
inclusion of MG-132 (Fig. 3A). Our previous work showed that
potentiation of cAMP signaling also prevents induction of persistent presynaptic silencing (Moulder et al., 2008), although the
mechanism underlying this protective effect is unclear. For this reason, we also asked whether 50 M forskolin (FSK), a potent adenylyl
cyclase activator, altered proteasome enzymatic activity. As seen in
Figure 3B, FSK treatment had no effect on proteasome activity, either under control conditions or after depolarization. This suggests
that cAMP signaling modulates presynaptic function either downstream of proteasome activity or through a parallel pathway.

Munc13-1 and Rim1 protein levels are reduced during
induction of persistent presynaptic silencing
If UPS-mediated protein degradation is an integral part of the
mechanisms underlying persistent presynaptic silencing, then
one or more protein targets of this pathway must be essential for
maintaining presynaptic function. Our previous work has shown
that synaptic vesicle number does not change at individual terminals after induction of presynaptic silencing (Moulder et al.,
2006) and that levels of synaptic vesicle proteins such as SV2 and
vGluT-1 are also unchanged (Moulder et al., 2004, 2006, 2008).
Furthermore, given that synaptic vesicle priming is likely compromised in silenced presynaptic terminals (Moulder et al.,
2006), we hypothesized that molecules implicated in priming are
the critical targets of the UPS. Munc13-1 stood out as an attractive candidate target for two reasons: first, the similarity of the
presynaptic silencing phenotype (as demonstrated in Fig. 1) and
that of Munc13-1⫺/⫺ neurons; second, the selective dependence
of glutamatergic, but not GABAergic, neurons on Munc13-1 for
neurotransmitter release (Augustin et al., 1999; Varoqueaux et
al., 2002), which could potentially explain the lack of an effect of
strong depolarization on the RRP of GABAergic neurons (Moulder
et al., 2004). Although expression of a Munc13-1–YFP fusion

Figure 3. Strong depolarization increases proteasome enzymatic activity. A, Representative
example (left) and normalized summary (right) of the chymotrypsin-like (LLVY) activity of the
proteasome measured in lysates from control neurons, after a 4 h exposure to 3 M MG-132, or
after depolarization in the presence or absence of MG-132. B, Representative example (left) and
normalized summary (right) of proteasome activity in control neurons, after a 4 h exposure to 50
M FSK, or after depolarization in the presence or absence of FSK. For summarized results,
n ⫽ 4 (A) or 3 (B) experiments. *p ⬍ 0.05 compared with the control baseline condition.

construct is not regulated by the proteasome (Kalla et al., 2006),
substantial evidence has confirmed that Dunc13, the Drosophila
ortholog of Munc13 isoforms, is degraded by the proteasome
(Aravamudan and Broadie, 2003; Speese et al., 2003).
We therefore examined Munc13-1 levels at glutamate synapses (identified using vGluT-1 labeling) by immunofluorescence after depolarization. Munc13-1 levels were decreased at
synaptic sites after a depolarizing challenge to produce silencing
(Fig. 4 A, C,E; average decrease of 41.2 ⫾ 4.8% in C and 27.0 ⫾
7.4% in E). Consistent with the idea that the protein was, in fact,
degraded rather than redistributed, no accompanying increase in
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Figure 4. Strong depolarization decreases Munc13-1 levels, which are rescued by MG-132 or forskolin. A, Representative images of vGluT-1 and Munc13-1 immunostaining in control neurons and
after depolarization. B, Representative Western blot image after depolarization, illustrating a decrease in Munc13-1 protein compared with a general protein marker, tubulin, or the synaptic protein
SV2. C, E, Summary of the average integrated intensity of Munc13-1 immunostaining at glutamate synapses after depolarization in the presence or absence of 3 M MG-132 or 50 M FSK. n ⫽ 15
each. For C, **p ⬍ 0.001 compared with the control baseline condition and *p ⬍ 0.005 compared with the depolarized baseline condition. For E, #p ⬍ 0.01 compared with the control baseline
condition, **p ⬍ 0.03 compared with the control baseline condition, and *p ⬍ 0.001 compared with the depolarized baseline condition. D, F, Summary of normalized quantitative results from
Western blot analyses in parallel experiments to C and E. Munc13-1 protein was normalized to SV2 protein levels within sample. n ⫽ 3 experiments each. For D, **p ⬍ 0.05 compared with the
control baseline condition and *p ⬍ 0.03 compared with the depolarized baseline condition. For F, #p ⬍ 0.01 compared with the control baseline condition, **p ⬍ 0.01 compared with the control
baseline condition, and *p ⬍ 0.03 compared with the depolarized baseline condition.

Munc13-1 immunofluorescence was seen in neurite areas adjacent to synaptic sites (average fluorescence intensity, 8680.9 ⫾
1610.6 AU for control and 6314.6 ⫾ 312.5 AU for depolarized
neurons; p ⬎ 0.05). Western blot analysis confirmed that total
cellular levels of Munc13-1 were also decreased by depolarization
compared with either the general protein marker tubulin or the
synaptic vesicle protein SV2 (Fig. 4 B, D,F; average decrease of
15.6 ⫾ 2.5% in D and 23.3 ⫾ 3.9% in F). We next assessed
whether the decreases in Munc13-1 protein expression were
blocked by agents that prevent induction of persistent presynaptic silencing. Addition of either 3 M MG-132 or 50 M FSK
maintained both synaptic (Fig. 4C,E) and cellular (Fig. 4 D, F )
levels of Munc13-1 in the face of depolarization. Surprisingly,
FSK addition also increased synaptic and cellular levels of
Munc13-1 from control levels in the absence of depolarization
(Fig. 4 E, F ).
Because it is unclear whether mammalian Munc13-1 is a direct target for degradation by the proteasome, we also examined
the levels of the priming protein Rim1 the ␣ isoform of which is a
target of proteasome degradation (Yao et al., 2007). We first examined Rim1 levels at glutamate synapses by immunofluorescence after depolarization, using an anti-Rim1 antibody that
recognizes a central epitope within both Rim1␣ and Rim1␤ isoforms (Kaeser et al., 2008b). Similar to Munc13-1, synaptic Rim1
protein levels decreased after depolarization (Fig. 5 A, C,E; average decrease of 35.6 ⫾ 6.2% in C and 37.4 ⫾ 9.8% in E). Also,
adjacent neuritic levels of Rim1 showed a similar decrease (average fluorescence intensity, 25,670.2 ⫾ 3271.8 AU for control and
7251.2 ⫾ 1830.4 AU for depolarized neurons; p ⬎ 0.001). Western blot analysis confirmed that depolarization depressed cellular
levels of Rim1␣ by 25.7 ⫾ 6.2% when normalized to tubulin
levels and by 21.8 ⫾ 4.4% when normalized to SV2 levels (Fig.

5 B, D,F; average decrease of 31.8 ⫾ 8.9% in D and 14.3 ⫾ 1.7% in
F ). Although expressed at a lower level than Rim1␣, the newly
identified, smaller Rim1␤ isoform (Kaeser et al., 2008b) was reduced as well (15.9 ⫾ 7.7% [tubulin] or 18.2 ⫾ 3.8% [SV2]).
Addition of either 3 M MG-132 or 50 M FSK maintained both
synaptic (Fig. 5C,E) and cellular (Fig. 5 D, F ) levels of Rim1␣ in
the face of depolarization. Again, FSK addition also increased
synaptic and cellular levels of Rim1 proteins from control levels
in the absence of depolarization (Fig. 5 E, F ).
Although Munc13-1 and Rim1 protein expression levels mirrored alterations in glutamate presynaptic function, it was unclear whether these changes were essential for the induction of the
persistent presynaptic silencing phenotypes. Therefore, we asked
whether protein expression level correlated with presynaptic
function at individual glutamate terminals. We depolarized hippocampal neurons and assessed presynaptic function using
FM1-43 uptake, followed by immunostaining for vGluT-1 and
Munc13-1 or vGluT-1 and Rim1. Average Munc13-1 and Rim1
levels were decreased at glutamate synapses after depolarization,
consistent with Figures 4 and 5 (30.7 ⫾ 7.5% decrease for
Munc13-1 and 37.5 ⫾ 3.1% decrease for Rim1). However, if we
separately analyzed the Munc13-1 and Rim1 levels at FM1-43positive (“active”) versus FM1-43-negative (“inactive”) synapses,
we found that Munc13-1 and Rim1 levels were consistently
higher in active synapses (Fig. 6). This was true both under basal
conditions and after depolarization, which induced many more
inactive synapses (Fig. 6 B, D). Our own and others’ previous results have demonstrated that a fraction of hippocampal presynaptic terminals are silent (inactive) even under basal conditions
(Rosenmund et al., 2002; Altrock et al., 2003; Moulder et al.,
2006; Ting et al., 2007). Furthermore, we could demonstrate a
correlation between FM1-43 uptake at individual synapses and
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Figure 5. Depolarization decreases Rim1 protein levels, which are rescued by MG-132 or forskolin. A, Representative images of vGluT-1 and Rim1␣/␤ immunostaining in control neurons and
after depolarization. B, Representative Western blot image after depolarization, illustrating a decrease in Rim1␣ protein compared with a general protein marker, tubulin, or the synaptic protein
SV2. C, E, Summary of the average integrated intensity of Rim1␣/␤ immunostaining at glutamate synapses after depolarization in the presence or absence of 3 M MG-132 or 50 M FSK. n ⫽
15–25 each. For C, **p ⬍ 0.001 compared with the control baseline condition and *p ⬍ 0.01 compared with the depolarized baseline condition. For E, #p ⬍ 0.001 compared with the control
baseline condition, **p ⬍ 0.005 compared with the control baseline condition, and *p ⬍ 0.001 compared with the depolarized baseline condition. D, F, Summary of normalized quantitative results
from Western blot analyses in parallel experiments to C and E. Rim1␣ protein was normalized to SV2 protein levels within sample. n ⫽ 3 experiments each. For D, **p ⬍ 0.03 compared with the
control baseline condition and *p ⬍ 0.05 compared with the depolarized baseline condition. For F, #p ⬍ 0.01 compared with the control baseline condition, **p ⬍ 0.02 compared with the control
baseline condition, and *p ⬍ 0.05 compared with the depolarized baseline condition.

the Munc13-1 (Fig. 6 E) or Rim1 (Fig. 6 F) levels at those synapses. The present data therefore suggest that synaptic Munc13-1
and Rim1 expression levels may partially dictate the ability of an
individual terminal to undergo proper synaptic vesicle cycling.
Because the stability of the entire active zone is dependent on
electrical activity under some conditions (Kalla et al., 2006), our
results with Munc13-1 and Rim1 proteins caused us to question
whether depolarization might trigger a turnover of the active
zone. We therefore examined the cellular and/or synaptic levels
of a number of other critical presynaptic proteins (Fig. 7). We
generally focused our analysis on proteins implicated in the synaptic vesicle priming process, as well as known protein kinase A
(PKA) substrates, given the ability of cAMP signaling to influence
presynaptic silencing (Moulder et al., 2008). We did not observe
a significant change in any presynaptic proteins other than
Munc13-1 and Rim1␣/␤ after depolarization. Therefore, although we have not exhausted all possibilities, our results suggest
that the measured decreases in Munc13-1 and Rim1 proteins
represent a relatively selective and targeted increase in protein
degradation.
Rim1␣ overexpression prevents induction of presynaptic
silencing and associated decreases in Munc13-1
If Rim1␣ loss is a direct or indirect cause of presynaptic silencing,
overexpression of Rim1␣ might overcome degradation and
prevent silencing. Therefore, we asked whether induction of
persistent presynaptic silencing could be prevented with overexpression of Rim1␣. We selected Rim1␣ for these experiments
because Munc13-1 protein expression appears to depend on the
continued presence of Rim1 proteins; total cellular levels of
Munc13-1 are decreased in brains from Rim1␣⫺/⫺ animals
(Schoch et al., 2002), whereas Rim1␣ levels are not altered in

Munc13-1⫺/⫺ neurons (Augustin et al., 1999). Furthermore, a
ubiquitin ligase termed Scrapper is responsible for the tagging
of Rim1␣ with ubiquitin and its subsequent degradation. In
Scrapper⫺/⫺ neurons, both Rim1␣ and Munc13-1 levels are increased, and in neurons from Scrapper transgenic (overexpressing) neurons, both Rim1␣ and Munc13-1 levels are decreased
(Yao et al., 2007). Therefore, we hypothesized that the observed
changes in Munc13-1 levels during silencing may be linked secondarily to decreases in Rim1␣ levels.
Hippocampal neurons in autaptic cultures were transfected
with GFP with or without Rim1␣ at 9 –11 DIV, and neurons were
depolarized 1 to 2 d later. Presynaptic function was assessed by
measuring action potential-evoked EPSC amplitude and the
charge of the sucrose-defined RRP (Fig. 8). We found that Rim1␣
overexpression slightly increased EPSC amplitude and the size of
the RRP under control conditions, although this effect was not
statistically significant (Fig. 8C,D) ( p ⬎ 0.05). When neurons
were depolarized, however, Rim1␣ overexpression prevented
the induction of persistent presynaptic silencing. Both action
potential-evoked EPSCs and sucrose responses were maintained
at control levels. These results indicate that presynaptic function
is preserved in the face of depolarization if Rim1 protein levels are
sufficiently high.
We also asked whether Rim1␣ overexpression prevented the
decrease in synaptic Munc13-1 levels induced by depolarization.
For these experiments, we used a synaptophysin–YFP fusion
construct to mark the presynaptic terminals of transfected
neurons. Neurons were transfected with synaptophysin–YFP
with or without Rim1␣ at 9 –14 DIV, and neurons were depolarized 1 d later, followed by immunocytochemistry for Munc13-1
and vGluT-1. A representative example of Munc13-1 and vGluT-1
immunostaining of synaptophysin–YFP-positive synapses is
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Figure 6. Synaptic Munc13-1 and Rim1 levels correlate with presynaptic function. A, Representative images of FM1-43FX uptake and Munc13-1 immunostaining at glutamate
synapses under control conditions and after depolarization. Note that Munc13-1 levels are lower at inactive synapses (FM1-43 ⫺/vGluT-1 ⫹; arrowheads) than at active synapses
(FM1-43 ⫹/vGluT-1 ⫹; arrows) in both conditions, although the percentage of inactive synapses in control cultures is much lower overall (see Fig. 1 D). B, Summary of average integrated
intensity of Munc13-1 immunostaining at active (FM1-43 ⫹) and inactive (FM1-43 ⫺) glutamate synapses. n ⫽ 220 (active) or 80 (inactive) for control and 72 (active) or 228 (inactive)
for the depolarized condition. *p ⬍ 0.001 compared with the active synapses in that condition. C, Representative images of FM1-43FX uptake and Rim1 immunostaining at glutamate
synapses under control conditions and after depolarization. Rim1 levels are also lower at inactive synapses (arrowheads) than at active synapses (arrows). Note that synaptic puncta size
is slightly smaller in C than in A attributable to differences in cell fixation. D, Summary of average integrated intensity of Rim1 immunostaining at active and inactive glutamate synapses.
n ⫽ 228 (active) or 122 (inactive) for control and 93 (active) or 257 (inactive) for the depolarized condition. *p ⬍ 0.01 compared with the active synapses in that condition. E, F, Measures
of FM1-43FX integrated intensity values at individual synapses plotted as a function of the Munc13-1 (E) or the Rim1 (F ) integrated intensity values. Data are from the same glutamate
synapses as in B and D. For E, r 2 ⫽ 0.785; p ⬍ 0.001. For F, r 2 ⫽ 0.599; p ⬍ 0.001.

shown in supplemental Figure 1 (available at www.jneurosci.
org as supplemental material). Consistent with our electrophysiology results, we found that Rim1␣ overexpression
maintained synaptic Munc13-1 levels at glutamate synapses
after depolarization (Fig. 8 E). These data are also consistent
with the idea that Munc13-1 protein stability is linked with
Rim1 protein expression. Therefore, degradation of Rim1
proteins likely plays a causative role in the induction of persistent presynaptic silencing.

Discussion
Over the past decade, increasing attention has revealed the
impact of the UPS on neuronal function. Potential defects in
proteasomal degradation have been linked to many neurodegenerative diseases, such as Alzheimer’s disease and Huntington’s disease (for review, see Hegde and Upadhya, 2007). Even
under physiological conditions, the UPS helps to regulate synaptogenesis and synaptic plasticity. Our results show a critical
role for the UPS in the modulation of glutamate release from
the presynaptic terminal. Furthermore, the observation that
targeted degradation of the synaptic vesicle priming proteins
Rim1 and Munc13-1 compromises glutamatergic signaling
supports a prominent role for these proteins in the maintenance of presynaptic function. Our experiments suggest that

neuronal activity exploits this pathway to elicit homeostatic
downregulation of glutamate release after a period of increased activity.
Munc13-1 and Rim1 are selectively targeted during induction
of presynaptic silencing
We observed a decrease in both the synaptic and cellular levels of
Munc13-1 and Rim1 proteins after depolarization (Figs. 4, 5).
These decreases were not attributable to a general turnover of the
presynaptic active zone because several other proteins maintained their expression levels in the face of tonic depolarization
(Fig. 7). Furthermore, overexpression of Rim1␣ prevented the
induction of persistent presynaptic silencing (Fig. 8). These data
are consistent with the idea that Munc13-1 and Rim1 proteins
play critical roles in synaptic vesicle release and suggest that
Munc13-1 and Rim1 proteins are selectively targeted by electrical
activity in the regulation of this process. We were surprised that
Rim1␣ overexpression did not significantly increase EPSC amplitude or RRP size under control conditions (Fig. 8) given that
inhibition of Rim1␣ degradation increases quantal glutamate release (Yao et al., 2007). This is likely attributable to cell-to-cell
variability in synapse number in autaptic cultures, resulting in
overlapping postsynaptic response sizes between the two treatment groups.
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Munc13-1 versus Rim1 proteins as
direct targets of the UPS
Our immunoblot analyses revealed that
cellular levels of both Rim1␣ and the
newly identified Rim1␤ isoform (Kaeser
et al., 2008b) were decreased by depolarization. This suggests, but does not prove,
that Rim1␤ is a direct target of the proteasome, as has been shown for Rim1␣ (Yao
et al., 2007). Related to this question is
whether Munc13-1 is degraded by the
proteasome or whether its stability relies
instead on the presence or absence of
Rim1 proteins. Substantial work has
shown that Dunc13, the Drosophila ortholog of Munc13 isoforms, is degraded
by the proteasome (Aravamudan and
Broadie, 2003; Speese et al., 2003). However, one report suggests that a Munc131–YFP construct is not regulated by the
proteasome (Kalla et al., 2006). In this instance, it is possible that the YFP moiety
enhances Munc13-1 stability. The idea
that Munc13-1 decreases are secondary to
Rim1 protein degradation stems from the
observation that total cellular levels of
Munc13-1, but not Munc13-2, are decreased in Rim1␣⫺/⫺ animals (Schoch et
al., 2002). Conversely, Rim1␣ levels are
not altered in Munc13-1⫺/⫺ neurons
(Augustin et al., 1999). Our observation
that Rim1␣ overexpression can both
prevent induction of persistent presynaptic silencing and maintain synaptic levels of Munc13-1 is consistent with the
latter scenario. However, it would still be informative to determine whether Munc13-1
can be targeted directly for UPS-mediated
degradation.
It is important to note that persistent
presynaptic silencing is a plastic response
to electrical activity or depolarization and
that presynaptically silenced synapses regain function within hours (Moulder et
al., 2004, 2008). In the context of the
present results, it will be interesting to
probe recovery mechanisms in more detail. Specifically, the question arises as to
how synaptic vesicle cycling is restored after degradation of synaptic Munc13-1 and
Rim1 proteins.

Figure 7. Several presynaptic proteins are unaffected by depolarization. A, Representative Western blot images from
control neurons and after depolarization. As noted in Materials and Methods, some Western blots were performed using
tissue from acute hippocampal slices to increase the amount of total protein available for Western blot analysis. We have
confirmed previously that persistent presynaptic silencing can be induced in acute hippocampal slices (Moulder et al.,
2004). B, Representative images of immunostaining in control neurons and after depolarization. Note that synaptic puncta
size can vary attributable to differences in cell fixation and permeabilization. C, Summary of normalized quantitative
results from Western blot analyses. The candidate proteins were normalized to SV2 (left) or tubulin (right) protein levels
within sample. n ⫽ 3 experiments each. Values shown are the percentage of control measured in the depolarized condition. No statistically significant differences were observed after depolarization. vGluT-1 was normalized to SV2 only
because of the similarity in size with tubulin. Examples of SV2 Western blot images can be seen in Figures 4 and 5.
D, Summary of the average integrated intensity of candidate protein immunostaining at glutamate synapses after depolarization. Analysis was restricted to glutamate synapses through colocalization with vGluT-1 immunostaining. n ⫽
10 –15 each. No statistically significant differences were observed after depolarization. A lack of difference in synaptic SV2
and vGluT-1 immunostaining after depolarization has been reported previously (Moulder et al., 2004, 2006).

Munc13-1 and Rim1 levels correlate
with presynaptic function
We also observed that presynaptic function is correlated with
levels of Munc13-1 and Rim1 in glutamatergic neurons (Fig. 6).
Notably, this was true even under basal levels of activity. Therefore, neurons likely use the mechanisms underlying persistent
presynaptic silencing to maintain a fraction of inactive synapses
even with physiological activity, as we have suggested previously
(Moulder et al., 2006). The premise for examining Munc13-1 and
Rim1 during and after a prolonged change in activity is that syn-

aptic levels of these proteins may determine whether or not a
given synapse has functional synaptic vesicle cycling. We appreciate, however, that, although we have examined several presynaptic proteins, including many implicated in synaptic vesicle
priming (Fig. 7), we have not eliminated the possibility that other
proteins may also contribute to presynaptic silencing mechanisms. Given that the roles of many presynaptic proteins are still
ill defined, this possibility would be virtually impossible to test
fully. Regardless of which proteins are involved, overexpression
of a single candidate protein, Rim1␣, rescued presynaptic func-
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changes in the subunit composition of the 20S proteasome
core or through differences in associating proteins, including
components of the 19S proteasome cap (Young et al., 2008).
Core subunits and associating proteins can also be modified
posttranslationally (Zhang et al., 2003), including via phosphorylation (Zhang et al., 2007b), with mixed effects on
function.

tion (Fig. 8). The most parsimonious explanation is that Rim1␣
loss is directly important for synaptic silencing, and overcoming
this loss prevents silencing.

Potential interactions between cAMP signaling and the UPS
Phosphorylation of proteasome subunits via PKA has been reported to increase proteasome enzymatic activity (Upadhya et al.,
2006; Zhang et al., 2007a). In our experiments, we found that 4 h
treatment with FSK had no effect on proteasome enzymatic activity, either under control conditions or coincident with depolarization (Fig. 3). FSK should increase cAMP levels, which in
turn should activate PKA. Differences in the length of PKA activation (Zhang et al., 2007a) or in the preparation used during
PKA activation (intact neurons vs cell extracts) (Upadhya et al.,
2006) likely explain why we did not detect an effect of FSK on
proteasome activity in our system.
Our results also leave open the question of how cAMP signaling pathways and the UPS-mediated degradation interact in
terms of modulating presynaptic function. Both FSK and MG132 prevent induction of presynaptic silencing (Fig. 1) (Moulder
et al., 2008), and both block depolarization-induced decreases in
Munc13-1 and Rim1 proteins (Figs. 4, 5). Rim1␣ has two consensus sites for PKA phosphorylation (Lonart et al., 2003) and is
a direct target of the UPS (Yao et al., 2007), thereby making it an
attractive candidate for the intersection of these two pathways.
However, the importance of the serine 413 PKA phosphorylation
site in several models of synaptic plasticity has been questioned
recently (Kaeser et al., 2008a), suggesting that the mechanism
might be considerably more complicated. The significance of
serine 413 phosphorylation is not known, but it does not appear
to affect Rim1 protein trafficking (for review, see Kaeser and
Südhof, 2005). It is possible that Rim1 phosphorylation affects its
stability or, more specifically, its targeting to and degradation by
the proteasome. Such protection by PKA phosphorylation has
been described for other proteins (Gastel et al., 1998; Schomerus
et al., 2000; Hino et al., 2005). Last, because forskolin, but not
MG-132, treatment increased Munc13-1 and Rim1 levels even
under control conditions (Figs. 4, 5), it is possible that cAMP
signaling modulates new transcription and translation of these
proteins, as opposed to their degradation.

Strong depolarization modulates proteasome
enzymatic activity
Depolarization likely resulted in decreased levels of Munc13-1
and Rim1 proteins because depolarization increased proteasome
enzymatic activity (Fig. 3). These data are consistent with previously published work in which depolarization increased degradation of a GFP-based proteasomal activity reporter (Bingol and
Schuman, 2006). Potassium depolarization has also been shown
to decrease total levels of protein ubiquitination (Chen et al.,
2003), which may occur through a separate mechanism but could
in fact be attributable to enhanced degradation of ubiquitinated
proteins.
The mechanism by which tonic depolarization or increased
electrical activity may modulate proteasome enzymatic activity is
unclear. Surprisingly, although the UPS has been extensively investigated, the factors that upregulate or downregulate proteasome function are just beginning to be revealed (Zhang et al.,
2007b). Proteasome enzymatic activity can be altered through

Modulation of proteasome activity: special concerns
in neurons
Proteasome activity is higher at synapses than in the nucleus and
is regulated differentially (Upadhya et al., 2006). However, the
specificity of depolarization-induced increases in proteasome activity, in terms of both spatial restrictions and target selectivity, must be delineated. The ability of electrical activity to
interact with the proteasome to regulate synaptic vesicle pools
(Willeumier et al., 2006) is likely to fall under similar governance.
Proteasome inhibition increases the frequency of miniature
EPSC events, which is likely attributable in part to decreased
Rim1␣ degradation (Yao et al., 2007), but the full complement of
presynaptic UPS effects is far from clear. Our results suggest that
the UPS is recruited by neurons to help maintain target firing
rates by depressing glutamate release in the face of increased electrical activity. It will be of great interest to determine the precise
triggers for this mechanism as well as the means by which signaling pathways can alter its outcome.

Figure 8. Rim1␣ overexpression prevents induction of persistent presynaptic silencing.
A, B, Representative traces of autaptic action potential-evoked (A) and sucrose-evoked (B)
EPSCs recorded under control conditions and after depolarization in neurons transfected with
GFP alone or GFP plus Rim1␣. C, D, Summary of quantitative results from action potentialevoked EPSCs (C) and responses to hypertonic sucrose application (D) in transfected neurons.
n ⫽ 13 each; *p ⬍ 0.001 compared with the depolarized condition transfected with GFP alone.
E, Summary of Munc13-1 integrated intensity at glutamatergic terminals of transfected neurons. n ⫽ 214 – 453 synapses per condition; *p ⬍ 0.001 compared with the depolarized condition transfected with synaptophysin–YFP (Syph-YFP) alone.
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Fässler R, Richter K, Boeckers TM, Potschka H, Brandt C, Löscher W,
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Kaeser PS, Südhof TC (2005) Rim function in short- and long-term plasticity. Biochem Soc Trans 33:1345–1349.
Kaeser PS, Kwon HB, Blundell J, Chevaleyre V, Morishita W, Malenka RC,
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